Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F W Fraunfelder

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cornea|December 19, 2006
Corneal toxicity from topical ocular and systemic medicationsF W Fraunfelder
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|May 1, 2004
Ocular hemorrhage possibly the result of HMG-CoA reductase inhibitorsF W Fraunfelder
Expert Opinion on Drug Safety|August 9, 2003
Ocular adverse drug reactionsF W Fraunfelder
Cornea|December 18, 2004
Liquid nitrogen cryotherapy of a conjunctival vascular tumorF W Fraunfelder, F T Fraunfelder
Ophthalmology|July 16, 2010
Interferon alfa-associated anterior ischemic optic neuropathyF W Fraunfelder, F T Fraunfelder
Ophthalmology|October 22, 2008
Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor useF W Fraunfelder, Amanda B Richards
Drugs of Today (Barcelona, Spain : 1998)|August 25, 2017
Keratitis in association with herpes zoster and varicella vaccinesA P Grillo, F W Fraunfelder
Expert Opinion on Drug Safety|October 31, 2007
Toxicities of topical ophthalmic anestheticsHall T McGee, F W Fraunfelder
Cornea|May 3, 2001
Laser in situ keratomileusis versus photorefractive keratectomy in the correction of myopic astigmatismF W Fraunfelder, S E Wilson
Drug Safety|November 5, 1997
Drug-induced uveitis. Incidence, prevention and treatmentF W Fraunfelder, J T Rosenbaum
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cornea|December 19, 2006
Corneal toxicity from topical ocular and systemic medicationsF W Fraunfelder
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|May 1, 2004
Ocular hemorrhage possibly the result of HMG-CoA reductase inhibitorsF W Fraunfelder
Expert Opinion on Drug Safety|August 9, 2003
Ocular adverse drug reactionsF W Fraunfelder
Cornea|December 18, 2004
Liquid nitrogen cryotherapy of a conjunctival vascular tumorF W Fraunfelder, F T Fraunfelder
Ophthalmology|July 16, 2010
Interferon alfa-associated anterior ischemic optic neuropathyF W Fraunfelder, F T Fraunfelder
Ophthalmology|October 22, 2008
Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor useF W Fraunfelder, Amanda B Richards
Drugs of Today (Barcelona, Spain : 1998)|August 25, 2017
Keratitis in association with herpes zoster and varicella vaccinesA P Grillo, F W Fraunfelder
Expert Opinion on Drug Safety|October 31, 2007
Toxicities of topical ophthalmic anestheticsHall T McGee, F W Fraunfelder
Cornea|May 3, 2001
Laser in situ keratomileusis versus photorefractive keratectomy in the correction of myopic astigmatismF W Fraunfelder, S E Wilson
Drug Safety|November 5, 1997
Drug-induced uveitis. Incidence, prevention and treatmentF W Fraunfelder, J T Rosenbaum
Pageof 2